Strategies of Pharmaceutical Companies
Added on 2022-09-02
15 Pages3033 Words20 Views
1
Business Strategy-Group Report
Date: -
Submitted to: -
Submitted by: -
Business Strategy-Group Report
Date: -
Submitted to: -
Submitted by: -
2
Table of Contents
Introduction:....................................................................................................................................4
History & Growth:...........................................................................................................................4
Revolution in Healthcare:............................................................................................................4
Facility of Services:.........................................................................................................................5
Pfizer Care:..................................................................................................................................5
Activities of the Company:..........................................................................................................5
Structure & Success Aspects:..........................................................................................................6
Values and Behaviors:.................................................................................................................6
Vision, Mission, & Corporate Tactics:............................................................................................7
Therapeutic Innovation:...............................................................................................................7
Authentic Collaboration:.............................................................................................................7
Business Strategy:............................................................................................................................8
Use of social media:.....................................................................................................................8
Development of positive relationships:.......................................................................................8
Technology:.................................................................................................................................8
Critical Marketing:.......................................................................................................................9
Functional Strategy:.........................................................................................................................9
Engaging with the viewers and public:........................................................................................9
International and communal investments:.................................................................................10
Table of Contents
Introduction:....................................................................................................................................4
History & Growth:...........................................................................................................................4
Revolution in Healthcare:............................................................................................................4
Facility of Services:.........................................................................................................................5
Pfizer Care:..................................................................................................................................5
Activities of the Company:..........................................................................................................5
Structure & Success Aspects:..........................................................................................................6
Values and Behaviors:.................................................................................................................6
Vision, Mission, & Corporate Tactics:............................................................................................7
Therapeutic Innovation:...............................................................................................................7
Authentic Collaboration:.............................................................................................................7
Business Strategy:............................................................................................................................8
Use of social media:.....................................................................................................................8
Development of positive relationships:.......................................................................................8
Technology:.................................................................................................................................8
Critical Marketing:.......................................................................................................................9
Functional Strategy:.........................................................................................................................9
Engaging with the viewers and public:........................................................................................9
International and communal investments:.................................................................................10
3
Worldwide well-being fellow:...................................................................................................10
Issues and Covid-19.......................................................................................................................10
Recommendations:........................................................................................................................11
Conclusion:....................................................................................................................................11
References......................................................................................................................................12
Worldwide well-being fellow:...................................................................................................10
Issues and Covid-19.......................................................................................................................10
Recommendations:........................................................................................................................11
Conclusion:....................................................................................................................................11
References......................................................................................................................................12
4
Introduction:
The report under discussion describes a pharmaceutical industry of Australia. The
industry that has been chosen for this description is known as Pfizer [ CITATION Pfi19 \l
1033 ]. The report illustrates the background information and history of the company. The
factors and features that lead to the success and growth of the organization are determined in this
report. It also examines the vision and mission of Pfizer. The corporate, business and functional
strategies can lead to the success of the pharmaceutical industry, are also demonstrated in this
context. The issues and challenges faced by the organization are also illustrated in this report as
well as the response of the industry during Covid-19. Some recommendations to overcome these
issues and other mitigations are elaborated in the report.
History & Growth:
Pfizer was discovered in 1849 by Charles Pfizer and Charles F. Erhart. Pfizer is regarded
as one of the largest biopharmaceutical industries located in Sydney, Australia [ CITATION
Par19 \l 1033 ]. Pfizer has a long timeline in terms of its innovation with the advent of
technology and passage of time. In 1956 there were only six operations performed by Pfizer,
with different diseases, these had a huge impact on the lives of the people in Australia in the 60s.
These are the diseases that can be cured and managed by Pfizer through effective medications
through their skilled staff. Several different colleagues of the industry that have been following
the same old path of the employers have made it possible to cure all the viral disease in the
present era.
Introduction:
The report under discussion describes a pharmaceutical industry of Australia. The
industry that has been chosen for this description is known as Pfizer [ CITATION Pfi19 \l
1033 ]. The report illustrates the background information and history of the company. The
factors and features that lead to the success and growth of the organization are determined in this
report. It also examines the vision and mission of Pfizer. The corporate, business and functional
strategies can lead to the success of the pharmaceutical industry, are also demonstrated in this
context. The issues and challenges faced by the organization are also illustrated in this report as
well as the response of the industry during Covid-19. Some recommendations to overcome these
issues and other mitigations are elaborated in the report.
History & Growth:
Pfizer was discovered in 1849 by Charles Pfizer and Charles F. Erhart. Pfizer is regarded
as one of the largest biopharmaceutical industries located in Sydney, Australia [ CITATION
Par19 \l 1033 ]. Pfizer has a long timeline in terms of its innovation with the advent of
technology and passage of time. In 1956 there were only six operations performed by Pfizer,
with different diseases, these had a huge impact on the lives of the people in Australia in the 60s.
These are the diseases that can be cured and managed by Pfizer through effective medications
through their skilled staff. Several different colleagues of the industry that have been following
the same old path of the employers have made it possible to cure all the viral disease in the
present era.
End of preview
Want to access all the pages? Upload your documents or become a member.
Related Documents
GlaxoSmithKline plc: Recent Developments, Dividend Policy, Capital Structure, and Ratio Analysislg...
|15
|3779
|365
Strategic Management and Sustainabilitylg...
|11
|3495
|222
Strategic Management and Sustainability Assessment 1lg...
|12
|3170
|441
External and Internal Analysis of GlaxoSmithKline (GSK)lg...
|15
|3380
|258
Business Plan for Eat Goodness in UK Food and Retail Industrylg...
|12
|2501
|165
Strategic Management and Sustainability in AstraZeneca Plclg...
|11
|3568
|122